Comparison of two regimens of weekly paclitaxel plus gemcitabine in patients with metastatic breast cancer: propensity score–matched analysis of real-world data
Article in Therapeutic Advances in Drug Safety (January 2022)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Nanoliposomes as Multidrug Carrier of Gemcitabine/Paclitaxel for the Effective Treatment of Metastatic Breast Cancer Disease: A Comparison with Gemzar and Taxol
Article in Advanced Therapeutics (September 2020)
Ophiopogonin D suppresses TGF-β1-mediated metastatic behavior of MDA-MB-231 breast carcinoma cells via regulating ITGB1/FAK/Src/AKT/β-catenin/MMP-9 signaling axis
Article in Toxicology in Vitro (August 2020)